C-type natriuretic peptide (CNP) is an anti-proliferative peptide produced mainly in the vasculature and in the nervous system, which is a new potential marker in human prostate cancer (Lippert et al., 2015). The gene discussed is NPPC; the disease is prostate carcinoma.